“I don’t trust this hospital,” said Dr. Susan Moore said from a hospital bed in Indiana, the oxygen tube hid up to her nose. “It’s not like you treat patients.” Moore, a physician from Indianapolis who is being treated for COVID-19 at Indiana University Hospital North, died of the virus …
Read More »WHO study finds no benefit from remediation of COVID-19 deaths, hospital stays
According to clinical trials by the World Health Organization (WHO), the antiviral drug rimadesivir had no significant effect on the survival of civil-19 patients or on the length of their hospital stay. The results, released late Thursday, could potentially be a major blow to efforts to find a cure for …
Read More »The FDA extends the use of rimadasevir as a COVID-19 treatment
The Food and Drug Administration (FDA) announced late Friday that it was approving the use of the drug remedesivir for all patients hospitalized with coronavirus. The agency said in a press release that it would extend the authorization of emergency use of the drug, “to allow its use in the …
Read More »Gilead: FDA could extend the use of remdesivir despite mixed data
(Reuters) – The U.S. Food and Drug Administration was able to update its emergency use authorization for Gilead Sciences Inc’s (GILD.O) brakesivir of drugs to admit patients admitted to hospital with moderate COVID-19, despite mixed test results, the company’s top study said on Friday. FILE PHOTO: An ampoule of Ebola …
Read More »Gilead: FDA could extend the use of remdesivir despite mixed data
(Reuters) – The U.S. Food and Drug Administration was able to update its emergency use authorization for Gilead Sciences Inc’s (GILD.O) brakesivir of drugs to admit patients admitted to hospital with moderate COVID-19, despite mixed test results, the company’s top study said on Friday. FILE PHOTO: An ampoule of Ebola …
Read More »